Closing Bell: Cardiol Therapeutics Inc up on Monday (CRDL)

Cardiol Therapeutics Inc opened trading today at $2.90 and closed at $3.04. prices ranged from a low of $2.87 to a high of $3.09.

Shares boosted 4.83 percent from the previous day's close of $2.90.

Today across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).

Trading volume was 141,117 on 342 total trades, while having an average volume of 95,338 in the last five days.

Trading across the entire TSX saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, the shares have risen 164.35% in the last year, while this year, they have risen 176.36%.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $201.24 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Cardiol Therapeutics Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..